Novel pH-sensitive micelles generated by star-shape copolymers containing zwitterionic sulfobetaine for efficient cellular internalization.
pH-sensitive micelles are considered promising carriers for tumor targeted drug delivery. In this study, novel pH-sensitive star-shape copolymers of amphiphilic poly(epsilon-caprolactone)-b-poly(N, N-diethylaminoethyl methacrylate)-r-poly(N-(3-sulfopropyl)-N-methacryloxyethy-N, N-diethylammoniumbetaine) (4sPCLDEAS) are designed and synthesized with the combination of ring opening polymerization (ROP) and atom radical transferpolymerization (ATRP). The structure of the copolymers is characterized by proton nuclear magnetic resonance spectra (1HNMR). The poly(N-(3-sulfopropyl)-N-methacryloxyethy-N, N-diethylammoniumbetaine) segment is used instead of poly(ethylene glycol) (PEG) as hydrophilic block in the copolymers to form polymeric micelles. The micelles present spherical shape, narrow size distribution, and are reponsive to the acidity. The CMC of the micelles is as low as 1 x 10(-3) mg mL(-1). Doxorubin (DOX) is efficiently encapsulated in the micelles and the drug release is pH dependant. The cytotoxicity as well as the intracellular drug delivery of the micelles are investigated. The micelles are nontoxic to human cervical carcinoma (Hela) cells. The DOX-loaded micelles are internalized in Hela cells efficiently, which are better than that of hydrophilic doxorubicin hydrochloride (DOX x HCl). These pH-sensitive micelles are potential promising carriers for anti-cancer drug delivery.
College of Polymer Science and Engineering of Sichuan University, Sichuan University, Chengdu 610065, China.
Jun
J
Cao
Shuying
S
Zhai
Chenlong
C
Li
Bin
B
He
Yusi
Y
Lai
Yuanwei
Y
Chen
Xianglin
X
Luo
Zhongwei
Z
Gu
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000737:chemistry; D001622:Betaine / Q000031:analogs & derivatives* / Q000737:chemistry; D002462:Cell Membrane / Q000737:chemistry*; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000737:chemistry*; D004058:Diffusion; D004317:Doxorubicin / Q000008:administration & dosage* / Q000737:chemistry; D006367:HeLa Cells; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008422:Materials Testing; D008823:Micelles; D053769:Nanocapsules / Q000008:administration & dosage / Q000737:chemistry* / Q000648:ultrastructure*; D010316:Particle Size; D011108:Polymers / Q000737:chemistry*
D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D008823:Micelles; D053769:Nanocapsules; D011108:Polymers; D001622:Betaine; D004317:Doxorubicin; C483727:sulfobetaine